Trials / Completed
CompletedNCT02896920
Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness
Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on Hidradenitis Suppurativa (HS) Burden of Illness and Health Care Resources Utilization
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 165 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
This study assesses Humira's® real-life effectiveness in the management of dermatological manifestations of moderate to severe Hidradenitis Suppurativa (HS).
Conditions
Timeline
- Start date
- 2016-09-20
- Primary completion
- 2019-04-29
- Completion
- 2019-04-29
- First posted
- 2016-09-12
- Last updated
- 2020-05-01
Locations
22 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT02896920. Inclusion in this directory is not an endorsement.